IL18 and colitis: Additionally, experimental murine colitis models demonstrated that neutralizing antibodies against TNF-α, IL-12, or IL-18 prevent the onset of colitis which further indicate that proinflammatory immune responses predominate in inflamed mucosa (210, 213).